IL-8 Rabbit Polyclonal Antibody
Usd: 315 Special Discount
Specification
Catalog# ER1901-61
IL-8 Rabbit Polyclonal Antibody
-
WB
-
IHC-P
-
IF-Cell
-
FC
-
Human
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ER1901-61_Europe.pdf
- No MSDS Found
Overview
Product Name
IL-8 Rabbit Polyclonal Antibody
Antibody Type
Rabbit Polyclonal Antibody
Immunogen
Recombinant protein within Human IL8 aa 1-99 / 99.
Species Reactivity
Human
Validated Applications
WB, IHC-P, IF-Cell, FC
Molecular Weight
Predicted band size: 11 kDa
Positive Control
U-87 MG treated with 1μM Thapsigargin for 24 hours cell lysate, U-87 MG cells treated with 1μM Thapsigargin for 24 hours, human tonsil tissue, human skeletal muscle tissue, AGS.
Conjugation
unconjugated
RRID
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Immunogen affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IHC-P
-
1:50-1:100
-
IF-Cell
-
1:500
-
FC
-
1:50-1:100
Target
Function
IL-8, also known as neutrophil chemotactic factor, has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also stimulates phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis. In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, such as increases in intracellular Ca2+, exocytosis (e.g. histamine release), and the respiratory burst.IL-8 can be secreted by any cells with toll-like receptors that are involved in the innate immune response. Usually, it is the macrophages that see an antigen first, and thus are the first cells to release IL-8 to recruit other cells. Both monomer and homodimer forms of IL-8 have been reported to be potent inducers of the chemokine receptors CXCR1 and CXCR2. The homodimer is more potent, but methylation of Leu25 can block the activity of homodimers.
Background References
1. van Damme J.et.al.The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.Eur. J. Immunol. 20:2113-2118(1990).
Sequence Similarity
Belongs to the intercrine alpha (chemokine CxC) family.
Post-translational Modification
Several N-terminal processed forms are produced by proteolytic cleavage after secretion from at least peripheral blood monocytes, leukcocytes and endothelial cells. In general, IL-8(1-77) is referred to as interleukin-8. IL-8(6-77) is the most promiment form.; Citrullination at Arg-27 prevents proteolysis, and dampens tissue inflammation, it also enhances leukocytosis, possibly through impaired chemokine clearance from the blood circulation.
Subcellular Location
Secreted.
UNIPROT
Synonyms
(Ala-IL-8)77 antibody
(Ser-IL-8)72 antibody
9E3 antibody
Beta thromboglobulin like protein antibody
C-X-C motif chemokine 8 antibody
CEF-4 antibody
chemokine, CXC motif, ligand 8 antibody
CXCL8 antibody
Emoctakin antibody
GCP-1 antibody
Expand(Ala-IL-8)77 antibody
(Ser-IL-8)72 antibody
9E3 antibody
Beta thromboglobulin like protein antibody
C-X-C motif chemokine 8 antibody
CEF-4 antibody
chemokine, CXC motif, ligand 8 antibody
CXCL8 antibody
Emoctakin antibody
GCP-1 antibody
GCP/IL-8 protein I antibody
GCP/IL-8 protein II antibody
GCP/IL-8 protein III antibody
GCP/IL-8 protein IV antibody
GCP/IL-8 protein V antibody
GCP/IL-8 protein VI antibody
GCP1 antibody
Granulocyte chemotactic protein 1 antibody
IL-8 antibody
IL-8(1-77) antibody
IL-8(9-77) antibody
IL8 antibody
IL8/NAP1 form I antibody
IL8/NAP1 form II antibody
IL8/NAP1 form III antibody
IL8/NAP1 form IV antibody
IL8/NAP1 form V antibody
IL8/NAP1 form VI antibody
IL8_HUMAN antibody
Inteleukin 8 antibody
LECT antibody
LUCT antibody
Lymphocyte-derived neutrophil-activating factor antibody
LYNAP antibody
MDNCF antibody
MDNCF-b antibody
MDNCF-c antibody
MONAP antibody
Monocyte derived neutrophil activating peptide antibody
Monocyte derived neutrophil chemotactic factor antibody
Monocyte-derived neutrophil chemotactic factor antibody
Monocyte-derived neutrophil-activating peptide antibody
NAF antibody
NAP 1 antibody
NAP-1 antibody
NAP1 antibody
Neutrophil activating peptide 1 antibody
Neutrophil activating protein 1 antibody
Neutrophil-activating factor antibody
Neutrophil-activating protein 1 antibody
Protein 3 10C antibody
Protein 3-10C antibody
SCYB 8 antibody
SCYB8 antibody
Small inducible cytokine subfamily B member 8 antibody
T cell chemotactic factor antibody
T-cell chemotactic factor antibody
TSG 1 antibody
TSG1 antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of IL-8 on different lysates with Rabbit anti-IL-8 antibody (ER1901-61) at 1/2,000 dilution.
Lane 1: U-87 MG cell lysate
Lane 2: U-87 MG treated with 1μM Thapsigargin for 24 hours cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 11 kDa
Observed band size: 11 kDa
Exposure time: 30 seconds; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ER1901-61) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of U-87 MG cells treated with 1μM Thapsigargin for 24 hours labeling IL-8 with Rabbit anti-IL-8 antibody (ER1901-61) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-IL-8 antibody (ER1901-61) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-IL8 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER1901-61, 1/100) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue using anti-IL8 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER1901-61, 1/100) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Flow cytometric analysis of IL8 was done on AGS cells. The cells were fixed, permeabilized and stained with the primary antibody (ER1901-61, 1/100) (red). After incubation of the primary antibody at room temperature for an hour, the cells were stained with a Alexa Fluor 488-conjugated goat anti-rabbit IgG Secondary antibody at 1/500 dilution for 30 minutes.Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Aldometanib mitigates LPS-induced Lung fibroblasts injury through the activation of AMPK-mediated signaling pathways
Journal: Toxicon
DOI: 10.1016/j.toxicon.2025.108489
IF: 2.4
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
A Multifunctional miRNA Delivery System Based on Tetrahedral Framework Nucleic Acids for Regulating Inflammatory Periodontal Ligament Stem Cells and Attenuating Periodontitis Bone Loss
Journal: ACS Applied Materials & Interfaces
DOI:
IF: 8.3
Application: WB
Reactivity: Rat
Publish date: 2024 Dec
Alternative Products
Products with the same target and pathway
IL-8 Recombinant Rabbit Monoclonal Antibody [PSH10-96] - BSA and Azide free
Application: WB,FC
Reactivity: Human
Conjugate: unconjugated
IL-8 Recombinant Rabbit Monoclonal Antibody [PSH10-96]
Application: WB,FC
Reactivity: Human
Conjugate: unconjugated
IL-8 Rabbit Polyclonal Antibody
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
IL-8 Recombinant Rabbit Monoclonal Antibody [PSH10-97]
Application: WB
Reactivity: Human
Conjugate: unconjugated
IL-8 Recombinant Rabbit Monoclonal Antibody [PSH10-97] - BSA and Azide free
Application: WB
Reactivity: Human
Conjugate: unconjugated
IL-8 Rabbit Polyclonal Antibody
Application: ELISA,IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated